BAILARD, INC. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2021$370,000
-31.9%
11,7000.0%0.01%
-44.0%
Q4 2020$543,000
-6.9%
11,700
-33.9%
0.02%
-16.7%
Q3 2020$583,000
+15.4%
17,700
-3.8%
0.03%
+7.1%
Q2 2020$505,000
-74.7%
18,400
-72.4%
0.03%
-80.3%
Q1 2020$1,994,000
-58.4%
66,600
-77.0%
0.14%
-47.4%
Q4 2019$4,792,000
+52.7%
289,500
+67.9%
0.27%
+42.1%
Q3 2019$3,138,000172,4000.19%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders